Please assess the completion status of the following clinical trial:

Trial Title: Botswana Tenofovir Oral HIV Prophylaxis Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* citizen of Botswana 18-29 years old~* sexually active~* HIV uninfected~* Hepatitis B and C uninfected~* Calculated creatinine clearance \>= 60 mL/min~* hemoglobin \>= 8 gm/dL~* ALT and AST \<= 2x ULN~* total bilirubin \<= 1.5 mg/dL~* total serum amylase \<= 1.5x ULN~* Serum phosphorus \>= 2.2 mg/dL~* willing to use effective contraception~* living within 1 hours travel of study clinic~* pass comprehension test~* willing and able to give informed consent~Exclusion Criteria:~* history of significant renal or bone disease~* any chronic illness requiring ongoing prescription medication~* pregnant or breastfeeding~* planning to move away from site in the next year~* participating in another HIV prevention or vaccine safety trial~* any other clinical condition or prior therapy that, in the opinion of the study physician, would make the volunteer unsuitable for the study or unable to comply with the dosing requirements

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 29 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).